Tampa, Florida
Phase 1 colorectal cancer trials in Tampa, FL
22 Phase 1 colorectal cancer studies are recruiting participants at sites in Tampa as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Tampa at a glance
- 22 studies are recruiting at a site in Tampa.
- By phase: Phase 1 (16), Phase 1/2 (6).
- By sponsor: industry (20), university, hospital or other (2).
- Most recent update to one of these records: November 17, 2026.
Studies recruiting in Tampa
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Aktis Oncology, Inc.
- Study site
- Moffitt Cancer Center
- Registry record
- NCT07020117 · updated
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Study site
- H. Lee Moffitt Cancer Center and Research Institute
- Registry record
- NCT06324357 · updated
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 to 99
- All sexes
- Sponsor
- Erasca, Inc.
- Study site
- Moffitt Cancer Center
- Registry record
- NCT06983743 · updated
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kestrel Therapeutics, Inc.
- Study site
- Moffitt Cancer Center
- Registry record
- NCT07458347 · updated
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Moffitt Cancer Center
- Registry record
- NCT04929223 · updated
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Moffitt
- Registry record
- NCT07114601 · updated
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Moffitt
- Registry record
- NCT07213791 · updated
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Alterome Therapeutics, Inc.
- Registry record
- NCT06835569 · updated
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Bicara Therapeutics
- Study site
- H. Lee Moffitt Cancer Center and Research Institute, Inc
- Registry record
- NCT04429542 · updated
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Dispatch Biotherapeutics
- Study site
- Moffitt Cancer Center
- Registry record
- NCT07544589 · updated
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Exelixis
- Study site
- Exelixis Clinical Site #8
- Registry record
- NCT05176483 · updated
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
- Study site
- Moffitt Cancer Center
- Registry record
- NCT06625775 · updated
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- ALX Oncology Inc.
- Study site
- ALX Center 7
- Registry record
- NCT07085091 · updated
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Moffitt Cancer Center and Research Institute
- Registry record
- NCT06128551 · updated
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Moffitt Cancer Center
- Registry record
- NCT06445062 · updated
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Blueprint Medicines Corporation
- Study site
- Moffitt Cancer Center
- Registry record
- NCT07629960 · updated
Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Study site
- Moffitt Cancer Center
- Registry record
- NCT07487168 · updated
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- MOMA Therapeutics
- Registry record
- NCT06974110 · updated
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Lee Moffitt Cancer Center
- Registry record
- NCT06040541 · updated
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
- Study site
- Moffitt Cancer Center
- Registry record
- NCT06917079 · updated
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Moffitt Cancer Center
- Registry record
- NCT05379985 · updated
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- A2 Biotherapeutics Inc.
- Study site
- Moffitt Cancer Center
- Registry record
- NCT06682793 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Tampa, FL on ClinicalTrials.gov.
Ask about studies near Tampa
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Florida
All Florida locations
65 studies recruiting across 19 cities.
Sarasota
15 studies recruiting.
Jacksonville
13 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections